Results 111 to 120 of about 19,009 (196)

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

open access: yesJournal of Blood Medicine, 2015
Christopher Arthur,1 Jaroslav Cermak,2 Jacques Delaunay,3 Jirí Mayer,4 Grzegorz Mazur,5 Xavier Thomas,6 Agnieszka Wierzbowska,7 Mark M Jones,8 Erhan Berrak,8 Hagop Kantarjian9 1Department of Haematology, Royal North Shore Hospital, Sydney, NSW ...
Arthur C   +9 more
doaj  

Morphological evaluation of dysmyelopoiesis in decitabine-treated patients with myelodysplastic syndromes

open access: yesТерапевтический архив, 2013
AIM: To estimate a change in myelodysplasia in decitabine-treated patients with myelodysplastic syndromes (MDS)/MATERIAL AND METHODS: Thirteen MDS patients from a high-risk group were examined; 75 bone marrow puncture specimens and 67 bone marrow ...
V N Dvirnyk   +6 more
doaj  

Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance. [PDF]

open access: yesNat Commun
Liu J   +34 more
europepmc   +1 more source

Methylation-associated downregulation of CRABP1 marks an aggressive malignant epithelial cell state in thyroid carcinoma. [PDF]

open access: yesFront Cell Dev Biol
Fu T   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy